Explore the latest in gynecology from The JAMA Network, including recent advances in cancer screening, family planning, management of menopause symptoms, and more.
This survey study estimates the extent to which pharmacies in California are making pharmacist-prescribed contraception available since it was permitted, but not required, in April 2016.
This JAMA Patient Page describes the US Preventive Services Task Force’s recommendations on use of hormone therapy for primary prevention of chronic conditions in postmenopausal women.
This systematic review to support the 2017 update of the US Preventive Services Task Force Recommendation Statement on use of hormone therapy summarizes published evidence on the benefits and harms of hormone therapy for primary prevention of chronic conditions in postmenopausal women.
This Recommendation Statement from the US Preventive Services Task Force recommends against use of hormone therapy for primary prevention of chronic conditions in postmenopausal women (D recommendation).
This Viewpoint discusses the Trump administration’s 2017 change to ACA provisions, which exempts employers with religious or moral objections to contraception from including coverage for contraceptives in their insurance plans.
Using a Markov simulation model based on the United Kingdom Collaborative Trial of Ovarian Cancer Screening clinical trial, this study examines the cost-effectiveness of multimodal screening for ovarian cancer in the United States and the association of screening with mortality.
This Viewpoint discusses the potential harms of perimenopausal and postmenopausal women taking compounded bioidentical hormone therapy not approved by the US Food and Drug Administration.
This JAMA Patient Page explains who should be tested for BRCA1/2 mutations and what the test results mean.
This Viewpoint offers considerations for health care professionals when discussing long-acting reversible contraceptives with adolescent girls.
This phase1/2 trial evaluates the safety and antitumor activity of ipilimumab in women with recurrent cervical cancer.
This observational study uses incidence rates before and after adoption of the Affordable Care Act (ACA) to assess whether adoption of the ACA increased screening for breast, colorectal, and cervical cancer.
This Viewpoint discusses the likely effects of the Trump administration’s discontinuation of teen pregnancy prevention programs that have proved to be successful.
This Medical Letter review summarizes treatment options for dyspareunia, focusing on use of intravaginal prasterone for treatment of moderate to severe dyspareunia in postmenopausal women.
This cohort study examines the prognostic role of CD8+ T lymphocytes for survival among women with epithelial ovarian cancer.
This cohort study investigates associations between biomarkers of ovarian reserve and reproductive potential among women of late reproductive age.
This secondary analysis of a randomized clinical trial examines DNA samples and family history of patients with triple-negative breast cancer to determine response to and survival from neoadjuvant treatment.
This study examines 5-year outcomes after cytology showing atypical squamous cells of undetermined significance among women with vs without human papillomavirus testing.